FIG. 4.
Intravenous administration of Toca 511 with 5-FC demonstrates survival efficacy in immune-competent orthotopic mouse glioma model. (a) Tu-2449 tumor in an immune-compromised mouse model; (b) Tu-2449 tumor in an immune-competent mouse model
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.